16.04.2020
- French pharma Servier has agreed to buy Danish biotech Symphogen for an undisclosed sum. Headquartered in Copenhagen, Symphogen has created an antibody discovery and research...
12.01.2016
- In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...